SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-17-338906
Filing Date
2017-11-09
Accepted
2017-11-09 16:46:55
Documents
3
Group Members
COLUMBIA MANAGEMENT INVESTMENT ADVISERS, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d488261dsc13ga.htm SC 13G/A 44493
2 EX-99.I d488261dex99i.htm EX-99.I 1141
3 EX-99.II d488261dex99ii.htm EX-99.II 3748
  Complete submission text file 0001193125-17-338906.txt   51335
Mailing Address 1099 AMERIPRISE FINANCIAL CENTER MINNEAPOLIS MN 55474
Business Address 1099 AMERIPRISE FINANCIAL CENTER MINNEAPOLIS MN 55474 612-671-8001
AMERIPRISE FINANCIAL INC (Filed by) CIK: 0000820027 (see all company filings)

IRS No.: 133180631 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6282 Investment Advice

Mailing Address 450 W. 15TH STREET SUITE 505 New York NY 10011
Business Address 450 W. 15TH STREET SUITE 505 NEW YORK NY 10011 646-747-1000
INTERCEPT PHARMACEUTICALS INC (Subject) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87033 | Film No.: 171191530
SIC: 2834 Pharmaceutical Preparations